Newsroom

Seventeen Foley & Lardner LLP attorneys and five firm jurisdictions have been recognized in the 2025 edition of IAM Patent 1000: The World’s Leading Patent Practitioners.

Foley & Lardner LLP senior counsel Roberto Fernandez assessed new procedures at the U.S. Patent and Trademark Office (USPTO) in the Law360 article, "New Procedures Expected To Result In More PTAB Denials."

Foley & Lardner LLP senior counsel Nikhil Pradhan shared insight on recent draft guidance from the U.S. Food and Drug Administration's in the MedCentral article, "FDA Draft Guidance Addresses Drug Submissions that Use AI Data."

Foley & Lardner LLP partner Alex Neuworth is recognized by Milwaukee Business Journal as a 2025 40 Under 40 honoree.

Foley & Lardner LLP partner Brian Tomkins is featured across legal press for his recent arrival to the firm.

Foley & Lardner LLP announced today that the firm has bolstered its Innovative Technology and Health Care & Life Sciences Sectors with the addition of Brian Tomkins as a partner in the Mechanical & Electromechanical Technologies Practice Group.

Foley & Lardner LLP partner Christopher King's comments on M&A due diligence at the Association of Corporate Counsel's annual meeting were highlighted in the Legal Dive article, "Can this marriage work? Legal tips for corporate M&A."

Fourteen Foley & Lardner LLP attorneys and four firm jurisdictions have been recognized in the 2024 edition of the IAM Patent 1000: The World’s Leading Patent Practitioners.

Foley & Lardner LLP partner Nicholas Zepnick is quoted in the Technology Transfer Tactics newsletter, discussing how to manage co-developed innovations and address licensing and commercialization issues as they relate to data use in artificial intelligence systems.